Intercept Pharmaceuticals, Inc. logo

Intercept Pharmaceuticals, Inc.

NASDAQ:ICPT

Overview | Financials
Company Name Intercept Pharmaceuticals, Inc.
Symbol ICPT
Currency USD
Price 19
Market Cap 794,694,000
Dividend Yield 0%
52-week-range 8.82 - 21.86
Industry Biotechnology
Sector Healthcare
CEO Mr. Jerome B. Durso
Website https://www.interceptpharma.com

An error occurred while fetching data.

About Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in

Related Stocks

Nano-X Imaging Ltd. logo

Nano-X Imaging Ltd.

NNOX

5.77 USD

Cullinan Oncology, Inc. logo

Cullinan Oncology, Inc.

CGEM

15.78 USD

Inhibrx, Inc. logo

Inhibrx, Inc.

INBX

15.8 USD

ANI Pharmaceuticals, Inc. logo

ANI Pharmaceuticals, Inc.

ANIP

58.19 USD

Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc.

CRBU

2.21 USD

Century Therapeutics, Inc. logo

Century Therapeutics, Inc.

IPSC

1.26 USD

Financials

Numbers are in millions USD

Numbers are in millions USD